Rimax Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ghaziabad, Uttar Pradesh, India, established in 2016.
2016 Ghaziabad, Uttar Pradesh, India Active
Last Updated:
Access Report
About Rimax Pharmaceuticals Private Limited

Rimax Pharmaceuticals Private Limited, a active private limited company, was established on 06 December 2016 in Ghaziabad, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U51909UP2016PTC088144. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sudipta Das (Director), Sidhartha Sekhar Sinha (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bs-7,Basement Ansal'S Sundaram Rdc, Raj Nagar,Ghaziabad, Ghaziabad, Uttar Pradesh, 201001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909UP2016PTC088144

  • Registration Number

    088144

  • Incorporation Date

    06 December 2016

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Profit Growth **** 246.33%
  • Ebitda **** 315.32%
  • Net Worth 36.00%
  • Total Assets **** 35.70%
Company report

Rimax Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rimax Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Rimax Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sudipta Das Director 06 Dec 2016 Current
Sidhartha Sekhar Sinha Director 06 Dec 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rimax Pharmaceuticals.

Rimax Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 246.33% increase in profit. The company's net worth Soared by an impressive increase of 36%.

Rimax Pharmaceuticals revenue growth over time
Rimax Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 35.70%
*******
*******
*******
*******
Profit or Loss
*******
 246.33%
*******
*******
*******
*******
Net Worth
*******
 36.00%
*******
*******
*******
*******
EBITDA
*******
 315.32%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rimax Pharmaceuticals?

In 2019, Rimax Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rimax Pharmaceuticals?

Unlock and access historical data on people associated with Rimax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rimax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rimax Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rimax Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Rimax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Rimax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.

  • Director Appointment

    Sudipta Das was appointed as a Director was appointed as a Director on 06 Dec 2016 & has been associated with this company since 9 years 2 months . was recorded as a recent event.

  • Director Appointment

    The activity Sidhartha Sekhar Sinha was appointed as a Director was appointed as a Director on 06 Dec 2016 & has been associated with this company since 9 years 2 months . was completed.

  • Company Incorporation

    The activity Rimax Pharmaceuticals Private Limited was registered on 06 Dec 2016 with Roc Kanpur & aged 9 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rimax Pharmaceuticals Private Limited?

The CIN of Rimax Pharmaceuticals Private Limited is U51909UP2016PTC088144.

Where is Rimax Pharmaceuticals Private Limited headquartered?

Rimax Pharmaceuticals Private Limited is headquartered at Bs-7,Basement Ansal'S Sundaram Rdc, Raj Nagar,Ghaziabad, Ghaziabad, Uttar Pradesh, 201001.

When was Rimax Pharmaceuticals Private Limited incorporated?

Rimax Pharmaceuticals Private Limited was incorporated on 06 December 2016.

Who are the current directors of Rimax Pharmaceuticals Private Limited?

The current directors of Rimax Pharmaceuticals Private Limited are

What is the primary industry of Rimax Pharmaceuticals Private Limited?

The primary industry of Rimax Pharmaceuticals Private Limited is Pharma.

Is Rimax Pharmaceuticals Private Limited a listed company?

Rimax Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Rimax Pharmaceuticals Private Limited?

The authorized capital of Rimax Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Rimax Pharmaceuticals Private Limited?

The compliance status of Rimax Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available